Additionally, CsnB also acts as a candidate to downregulate CD36/FABP4 expression, leading to the inhibition of fatty acid uptake and consequent breast cancer cell proliferation in NR4A1-dependent manner (41). This evidence concerns the gene FABP4 and breast cancer.